Products for Research Use Only
RegisterLogin

Paclitaxel-13C6

CAT: 0804-HY-W768912-01Size: 500 µgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-W768912-01Size:500 µg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Paclitaxel-13C6 is the 13C-labeled Paclitaxel. Paclitaxel is a naturally occurring antineoplastic agent and stabilizes?tubulin?polymerization. Paclitaxel can cause both mitotic arrest and?apoptotic?cell death. Paclitaxel also induces?autophagy[1][2].
UNSPSC
12352005
Target
ADC Payload; Apoptosis; Autophagy; Isotope-Labeled Compounds; Microtubule/Tubulin
Related Pathways
Antibody-drug Conjugate/ADC Related; Apoptosis; Autophagy; Cell Cycle/DNA Damage; Cytoskeleton; Others
Applications
Cancer-programmed cell death
Field of Research
Cancer
Smiles
O=C([C@]1([C@@H]([C@@H]([C@@]2(C[C@@H](C(C)=C3C2(C)C)OC([C@H]([C@@H](C4=CC=CC=C4)NC(C5=CC=CC=C5)=O)O)=O)O)OC([13C]6=[13C]([13C]([H])=[13C]([13C]([H])=[13C]6[H])[H])[H])=O)[C@]7(OC(C)=O)CO[C@@H]7C[C@@H]1O)C)[C@@H]3OC(C)=O
Molecular Formula
C41 13C6H51NO14
Molecular Weight
859.86
References & Citations
[1]Choi YH, et al. Paclitaxel-induced growth arrest and apoptosis is associated with the upregulation of the Cdk inhibitor, p21WAF1/CIP1, in human breast cancer cells. Oncol Rep. 2012 Dec;28 (6) :2163-9.|[2]Dziadyk JM, et al. Paclitaxel-induced apoptosis may occur without a prior G2/M-phase arrest. Anticancer Res. 2004 Jan-Feb;24 (1) :27-36.
Shipping Conditions
Room temperature
Scientific Category
Isotope-Labeled Compounds
Clinical Information
No Development Reported

Related Products

CatalogName
HY-B0015-01Paclitaxel
HY-175981Paclitaxel-bromothiophene
HY-137776Paclitaxel C
HY-177146Paclitaxel-MVCP
HY-P99974-01Nab-Paclitaxel
HY-177999Paclitaxel-DBCO
HY-106146Paclitaxel ceribate
HY-D2422BCy5-Paclitaxel
HY-186000Paclitaxel-maleimide
HY-B0015S-01Paclitaxel-d5

Alternative Products

CatalogName
TRC-P132504-0.5MGPaclitaxel-13C6
abx185891-01(-)-Paclitaxel;Paclitaxel
BUP20834-01Paclitaxel

Popular Products